Phase 1 Study of Sildenafil (Viagra) Treatment of Subacute Ischemic Stroke.
Phase of Trial: Phase I
Latest Information Update: 15 Mar 2011
At a glance
- Drugs Sildenafil (Primary)
- Indications Stroke
- Focus Adverse reactions
- 31 Aug 2018 Biomarkers information updated
- 14 Apr 2009 Planned number of patients changed from 72 to 120 as reported by ClinicalTrials.gov.
- 14 Apr 2009 Planned end date changed from 1 Feb 2011 to 1 Feb 2012 as reported by ClinicalTrials.gov.